Research Article

A Meta-Analysis of Resveratrol Protects against Myocardial Ischemia/Reperfusion Injury: Evidence from Small Animal Studies and Insight into Molecular Mechanisms

Figure 2

Pooled estimates of infarct size for resveratrol vs. vehicle in vivo. Treatment with resveratrol was associated with a smaller infarct size in in vivo studies (WMD: -13.42, 95% CI: -16.63 to -10.21, ). Gray squares represent WMDs in studies. The 95% CIs for each studies are denoted by lines and those for the pooled WMDs by open diamonds. Meta-analysis is performed by random effects model.